BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...

A recall has been issued for a gel insert for car seats and strollers that was sold at Target stores nationwide after a child received medical attention with second-degree burns to his back. The U.S ...

What if a doctor could inject an electricity-conducting liquid into the body, let it temporarily solidify to record nerve signals or jump-start healing, and then return it to liquid form for easy ...

Advances in materials science are transforming medicine, engineering, and environmental technology. Among the most promising innovations are hydrogels—highly absorbent polymer networks with ...

The ideal material for interfacing electronics with living tissue is soft, stretchable, and just as water-loving as the tissue itself--in short, a hydrogel. Semiconductors, the key materials for ...

The company's experimental dry-eye treatment produced some disappointing clinical trial results. Ocular Therapeutix's only revenue-generating product, Dextenza, isn't making ends meet yet. Investors ...